Ivosidenib Oral Tablet Clinical Trials

1 actively recruiting trial across 1 location

▼ -1 trial since July 2026

Pipeline

Phase 1: 1

Top Sponsors

Servier Bio-Innovation LLC1

Indications

IDH1-Mutated Malignancies1
Cancer1

Atlanta, Georgia1 trial

A Study of an IDH1m Inhibitor in Participants With IDH1-Mutated Malignancies and Hepatic or Renal Impairment

Emory University

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.